Treatment of Central Precocious Puberty with a Focus on Girls

• Kanthi Bangalore Krishna ^[2] ; Karen O. Klein ^[1] ; Erica A. Eugster ^[3]
  1. [1] University of California System

     University of California System

     Estados Unidos

     
  2. [2] Division of Pediatric Endocrinology and Diabetes, UPMC Childrens Hospital of Pittsburgh, Pittsburgh, PA 15090, USA
  3. [3] Division of Pediatric Endocrinology, 705 Riley Hospital Drive, Indianapolis, IN 46202, USA.

  Mostrar afiliaciones +
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 53, Nº. 2, 2024, págs. 229-238
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The age of thelarche has declined in the past few decades but not the age of menarche. This is important when assessing girls who present with breast development between 6 and 8 years because not all of them will need treatment. The decision for treatment depends on age, bone age (BA), rate of pubertal progression, height velocity, psychosocial factors, and predicted adult height (PAH), with the caveat that height predictions are not precise and BA interpretation is variable.